12.50p+0.25 (+2.04%)28 Mar 2024, 17:08
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Angle PLC Fundamentals

Company NameAngle PLCLast Updated2024-03-28
IndustryDiagnostics & ResearchSectorHealthcare
Shares in Issue260.581 mMarket Cap£32.57 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.09EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.1139Debt Equity Ratio0.1235
Asset Equity Ratio1.2525Cash Equity Ratio0.6911
Quick Ratio5.9985Current Ratio7.51
Price To Book Value0.9954ROCE0

Angle PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Angle PLC Company Financials

Assets20222021
Tangible Assets£8.48 m£4.38 m
Intangible Assets£2.76 m£3.57 m
Investments00
Total Fixed Assets£11.24 m£7.95 m
Stocks£2.06 m£1.75 m
Debtors£1.77 m£1.21 m
Cash & Equivalents£31.90 m£31.84 m
Other Assets00
Total Assets£49.87 m£47.31 m
Liabilities20222021
Creditors within 1 year£5.25 m£4.91 m
Creditors after 1 year£4.55 m£2.07 m
Other Liabilities00
Total Liabilities£9.80 m£6.99 m
Net assets£40.06 m£40.33 m
Equity20222021
Called up share capital£26.06 m£23.51 m
Share Premium£115.92 m£99.41 m
Profit / Loss-£24.44 m-£17.36 m
Other Equity£40.06 m£40.33 m
Preference & Minorities00
Total Capital Employed£40.06 m£40.33 m
Ratios20222021
Debt Ratio£0.10£0.04
Debt-to-Equity£0.11£0.05
Assets / Equity1.25251.2525
Cash / Equity0.69110.6911
EPS-£0.08-£0.06
Cash Flow20222021
Cash from operating activities-£16.05 m-£14.01 m
Cashflow before financing£2.05 m£4.98 m
Increase in Cash£295,000.00£19.75 m
Income20222021
Turnover£1.04 m£1.01 m
Cost of sales£428,000.00£302,000.00
Gross Profit£613,000.00£711,000.00
Operating Profit-£24.21 m-£17.23 m
Pre-Tax profit-£24.44 m-£17.36 m

Angle PLC Company Background

SectorHealthcare
ActivitiesANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.
Latest Interim Date7 Sep 2023
Latest Fiscal Year End Date21 Apr 2023

Angle PLC Directors

AppointedNamePosition
2023-06-05Mr. Garth Robert SelveyNon-Executive Director
2023-03-10Mr. Andrew David William NewlandExecutive Director,Chief Executive Officer
2014-09-30Mr. David William Quysner CBENon-Executive Director
2023-03-10Mr. Ian Francis GriffithsExecutive Director,Finance Director and Company Secretary
2023-06-05Mr. Brian HowlettNon-Executive Director,Senior Independent Director
2011-08-09Dr. Hance Fullerton OBE LLDNon-Executive Director,Chairman

Angle PLC Contact Details

Company NameANGLE PLC
Address10 Nugent Road, The Surrey Research Park, Guildford, GU2 7AF
Telephone+44 1483295830
Websitehttps://www.angleplc.com

Angle PLC Advisors

Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
AuditorRSM
Phone0845 057 0700
Fax0845 057 0701
BankNational Westminster Bank PLC
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
StockbrokerCenkos Securities
Phone+44 2073978900
Fax+44 2073978901
SolicitorPinsent Masons LLP
Phone(020) 7418 7000
Fax(020) 7418 7050
Nominated AdviserCenkos Securities
Phone+44 2073978900
Fax+44 2073978901